Exosomes from senescent cells could revolutionize cancer therapy delivery
New research reveals how tiny cellular packages from aging cells might be engineered to deliver targeted cancer treatments.
20 articles
New research reveals how tiny cellular packages from aging cells might be engineered to deliver targeted cancer treatments.
French study explores how tiny cellular packages in blood could predict cancer recurrence and guide treatment decisions.
French researchers studied how tiny cellular packages called exosomes may help melanoma cells resist treatment and spread throughout the body.
Engineered immune cell vesicles first induce cancer cell senescence with chemo, then eliminate them with targeted senolytic drugs.
New liquid biopsy technique identifies molecular residual disease in colorectal cancer patients to guide personalized treatment decisions.
Surface proteins on tiny cellular packages could revolutionize early breast cancer detection through simple blood tests.
Small study explores cerebrospinal fluid exosomes to better diagnose breast cancer spread to brain and spinal cord.
Scientists explore how exosomes in urine samples could revolutionize early cancer detection through simple, non-invasive testing.
New diagnostic chip analyzes blood exosomes to detect early lung spread of bone cancer, potentially improving treatment outcomes.
Activated T cells release vesicles carrying genomic DNA that reprogram recipient cells to display tumor antigens more effectively.
A novel immune-evasion mechanism in triple-negative breast cancer reveals how cancer stem cells suppress anti-tumor immunity via extracellular vesicles.
A new DNA-based treatment blocks the PCSK9 protein, cutting LDL cholesterol by nearly 50% while avoiding common statin side effects.
Redesigned immunotherapy injected into one tumor triggered complete cancer remission in 2 of 12 patients, with untreated tumors also disappearing.
Novel nanoplatform delivers copper and iron ions to trigger both ferroptosis and cuproptosis in cancer cells.
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
Novel nanoparticle combines protein degrader with light therapy to reprogram cancer metabolism and eliminate breast tumors.
Researchers discover why combining chemotherapy with immunotherapy works better and identify a key resistance mechanism.
Scientists develop advanced drug delivery methods to detect and eliminate harmful senescent tumor cells that promote cancer spread.
Synthetic super-enhancers hijack glioblastoma's own regulatory circuits to trigger precise, tumor-only cell death and durable immune memory.
Scientists discover how to reprogram cancer cells into harmless, non-dividing cells by targeting a nuclear enzyme pathway.